‹ Screener

RH

RH · Retail-Furniture Stores · 18.9M shares · -3%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $1.2B (gross $1.3B, SBC $39M)

Reference price $144.00 · est. market cap ~$2.7B — last insider sale, 2026-06-18 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

B77

RH is a differentiated luxury home-furnishings brand with strong FCF and earnings rebound, but carries heavy leverage and cyclicality.

Strengths

Risks

Notable findings

Quarterly revenue

2017-01-28 · $587M2017-10-28 · $592M2018-11-03 · $637M2019-02-02 · $671M

Last 4 quarters · from SEC filings.

Key metrics

Return on equity
205.9%
Return on assets
2.6%
Revenue growth (QoQ)
5.4%
Net-income growth
72.3%
Current ratio
1.2×
Free cash flow
$252M
EBITDA
$536M
Tangible book value
-$84M
Cash & investments
$41M

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-18SCHLESINGER LEONARD AGrant843
2026-06-18ALBERINI CARLOSGrant843
2026-06-18Rowghani AliGrant843
2026-06-18Mitic Kathleen C.Grant843
2026-06-18Krane Hilary KGrant843
2026-06-18Belling KeithGrant843
2026-06-18DEMILIO MARK SSell3.1K$144.00
2026-06-18DEMILIO MARK SGrant843
2026-06-16DEMILIO MARK SSell2.2K$150.00
2026-04-14DEMILIO MARK SGrant13K
2026-04-06Chaya EriOption exercise25K$39.42
2026-03-31Chaya EriSell2.9K$139.38
2026-03-31Chaya EriOption exercise11K$39.42
2026-03-31Chaya EriSell1.1K$135.27
2026-03-31Chaya EriSell2.0K$135.93
2026-03-31Chaya EriSell1.6K$137.04
2026-03-31Chaya EriSell1.7K$138.21
2026-03-31Chaya EriSell1.7K$140.02
2026-03-30Hargarten ChristinaOption exercise1.1K
2026-03-24Chaya EriOption exercise7.0K$39.42
2026-03-24Chaya EriSell822$127.96
2026-03-24Chaya EriSell2.5K$128.74
2026-03-24Chaya EriSell2.2K$129.83
2026-03-24Chaya EriSell1.5K$130.74
2026-03-17Chaya EriSell3.3K$135.70
2026-03-17Chaya EriOption exercise7.0K$39.42
2026-03-17Chaya EriSell2.7K$134.50
2026-03-17Chaya EriSell1.0K$136.40
2026-01-31Chi LisaOption exercise6.0K
2026-01-14DEMILIO MARK SSell2.3K$220.00
2026-01-13DEMILIO MARK SSell2.0K$220.10
2025-12-31DEMILIO MARK SSell400$180.17
2025-12-30DEMILIO MARK SSell500$184.00
2025-09-19DEMILIO MARK SSell2.0K$236.13
2025-09-16DEMILIO MARK STax withheld3.3K$230.70
2025-09-16DEMILIO MARK SOption exercise20K$38.04
2025-06-26Mitic Kathleen C.Grant670
2025-06-26Belling KeithGrant670
2025-06-26SCHLESINGER LEONARD AGrant670
2025-06-26Rowghani AliGrant670
2025-06-26ALBERINI CARLOSGrant670
2025-06-26DEMILIO MARK SGrant670
2025-06-26Krane Hilary KGrant670
2025-03-30Hargarten ChristinaOption exercise750
2025-01-21Chaya EriOption exercise25K$39.42
2025-01-21Chaya EriSell22K$450.21
2025-01-21Chaya EriSell2.3K$451.56
2025-01-21Chaya EriSell245$452.55
2025-01-21Chaya EriSell335$453.74
2025-01-21Chaya EriSell234$454.62
2025-01-17Hargarten ChristinaOption exercise1.1K$154.82
2025-01-17Hargarten ChristinaOption exercise3.8K$101.25
2025-01-17Hargarten ChristinaSell1.1K$447.17
2025-01-17Hargarten ChristinaSell3.8K$447.17
2025-01-17Hargarten ChristinaSell480$447.55
2025-01-17Lee Edward TOption exercise600$154.82
2025-01-17Lee Edward TSell600$446.73
2025-01-14Chaya EriOption exercise25K$39.42
2025-01-14Chaya EriSell14K$425.35
2025-01-14Chaya EriSell3.5K$426.19
2025-01-14Chaya EriSell2.0K$427.37
2025-01-14Chaya EriSell5.3K$428.54
2025-01-14Chaya EriSell634$429.20
2025-01-06Chaya EriOption exercise10K$87.31
2025-01-06Chaya EriSell2.7K$414.01
2025-01-06Chaya EriSell1.3K$415.19
2025-01-06Chaya EriSell1.5K$416.04
2025-01-06Chaya EriSell1.4K$416.77
2025-01-06Chaya EriSell1.2K$417.91
2025-01-06Chaya EriSell1.9K$419.07
2025-01-06Belling KeithSell500$417.85

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT05847218 ↗Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers
Safety, Tolerability
PHASE1Completed2023-03-19
NCT00480207 ↗Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
Depression
PHASE2/PHASE3Completed2008-10-01

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Notable events (8-K)

DateItems
2026-06-25Shareholder votefiling ↗
2026-06-11ResultsExhibitsfiling ↗
2026-03-31ResultsExhibitsfiling ↗
2026-01-26Exec/director changefiling ↗
2025-12-11ResultsExhibitsfiling ↗
2025-09-11ResultsExhibitsfiling ↗
2025-08-06Material agreementDebt obligationExhibitsfiling ↗
2025-07-02Shareholder votefiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-06-252026-06-180001104659-26-077404 ↗
8-K2026-06-112026-06-110001104659-26-072941 ↗
10-Q2026-06-112026-05-020001104659-26-073006 ↗
10-K2026-04-012026-01-310001104659-26-037992 ↗
8-K2026-03-312026-03-310001104659-26-037775 ↗
8-K2026-01-262026-01-200001104659-26-006620 ↗
8-K2025-12-112025-12-110001104659-25-120343 ↗
10-Q2025-12-112025-11-010001104659-25-120354 ↗
8-K2025-09-112025-09-110001558370-25-012006 ↗
10-Q2025-09-112025-08-020001558370-25-012015 ↗
8-K2025-08-062025-07-310001558370-25-010517 ↗
8-K2025-07-022025-06-260001558370-25-009058 ↗